0001144204-18-052404.txt : 20181003
0001144204-18-052404.hdr.sgml : 20181003
20181003190054
ACCESSION NUMBER: 0001144204-18-052404
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180508
FILED AS OF DATE: 20181003
DATE AS OF CHANGE: 20181003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ford David A
CENTRAL INDEX KEY: 0001705295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 181106560
MAIL ADDRESS:
STREET 1: 7 OAKRIDGE ROAD
CITY: ANNANDALE
STATE: NJ
ZIP: 08801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tv503772_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-05-08
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001705295
Ford David A
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
0
1
0
0
Chief Human Resources Officer
Common Stock
2018-05-08
4
F
0
510
70.15
D
9662
D
Common Stock
2018-08-08
4
F
0
128
116.84
D
9662
D
Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock.
In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4.
/s/ Mark Pruzanski, as attorney-in-fact
2018-10-03